{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:07:04Z","timestamp":1791025624454,"version":"4.1.0"},"reference-count":23,"publisher":"American Public Health Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Public Health"],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:p> The Titanic has become a metaphor for the disastrous consequences of an unqualified belief in the safety and invincibility of new technology. Similarly, the thalidomide tragedy stands for all of the \"monsters\" that can be inadvertently or negligently created by modern medicine. Thalidomide, once banned, has returned to the center of controversy with the Food and Drug Administration's (FDA's) announcement that thalidomide will be placed on the market for the treatment of erythema nodosum leprosum, a severe dermatological complication of Hansen's disease. Although this indication is very restricted, thalidomide will be available for off-label uses once it is on the market. New laws regarding abortion and a new technology, ultrasound, make reasonable the approval of thalidomide for patients who suffer from serious conditions it can alleviate. In addition, the FDA and the manufacturer have proposed the most stringent postmarketing monitoring ever used for a prescription drug, including counseling, contraception, and ultrasonography in the event of pregnancy. The Titanic\/thalidomide lesson for the FDA and public health is that rules and guidelines alone are not sufficient to guarantee safety. Continuous vigilance will be required to ensure that all reasonable postmarketing monitoring steps are actually taken to avoid predictable and preventable teratogenic disasters. <\/jats:p>","DOI":"10.2105\/ajph.89.1.98","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T06:34:07Z","timestamp":1322807647000},"page":"98-101","source":"Crossref","is-referenced-by-count":50,"title":["Thalidomide and the Titanic: reconstructing the technology tragedies of the twentieth century."],"prefix":"10.2105","volume":"89","author":[{"given":"G J","family":"Annas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"844","reference":[{"key":"p_1","unstructured":"Hawthorn J. Cunning Passages: New Historicism, Cultural Materialism, and Marxism in the Contemporary Literary Debate. London, England: Arnold; 1996."},{"key":"p_2","unstructured":"Beesley L, Gracie A, Lightoller C, Bride H. The Story of the Titanic as Told by Its Survivors. Mineola, NY: Dover Publications Inc; 1960:94."},{"key":"p_3","doi-asserted-by":"publisher","DOI":"10.2307\/1123344"},{"key":"p_4","unstructured":"Insight Team of the Sunday Times of London. Suffer the Children: The Story of Thalidomide. New York, NY: Viking Press; 1979."},{"key":"p_5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)09038-7"},{"key":"p_6","first-page":"2555","volume":"86","author":"Lenz W","year":"1961","journal-title":"Dtsch Med Wochenschr."},{"key":"p_7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)90927-8"},{"key":"p_8","doi-asserted-by":"publisher","DOI":"10.1016\/S0095-5108(18)30810-8"},{"key":"p_9","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.29.10.716"},{"key":"p_10","unstructured":"Elias SE, Annas GJ. Reproductive Genetics and the Law. St. Louis, Mo: Mosby-Yearbook; 1987:207."},{"key":"p_11","doi-asserted-by":"crossref","unstructured":"Koren G, Pastusak A, Shinya I. Drugs in pregnancy. NEnglJMed. 1998;338:1126-1137.","DOI":"10.1056\/NEJM199804163381607"},{"key":"p_12","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#"},{"key":"p_13","unstructured":"Stolberg SG. Thalidomide wins FDA's approval. New York limes. July 17, 1998:1."},{"key":"p_14","unstructured":"Food and Drug Administration. FDA Talk Paper on Thalidomide. Washington, DC: Public Health Service; July 16, 1998."},{"key":"p_15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705223362103"},{"key":"p_16","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.79.11.1565"},{"key":"p_17","unstructured":"Roe v Wade, 410 U.S. 113 (1973)."},{"key":"p_19","unstructured":"Privacy and the Making of Roe v. Wade. New York, NY: Macmillan; 1994:285-289."},{"key":"p_21","first-page":"740","volume":"325","author":"Johnson Controls J","year":"1991","journal-title":"Med."},{"key":"p_23","unstructured":"cologists. Statement on Thalidomide. Washington, DC: American College of Obstetricians 23. Sharpe R. Med Watch system comes under and Gynecologists; August 27, 1997. fire: FDA defends drug monitoring as physi"},{"key":"p_25","unstructured":"nal. June 24, 1998:B5. mide returns with an unlikely ally-a group of 24. Hopkinson N. Advocacy group petitions FDA its original victims. New York Magazine. Janu- to ban diabetes drug troglitazone. Wall Street ary 25, 1998:24."},{"key":"p_26","unstructured":"Journal. July28,1998:B6."},{"key":"p_28","first-page":"1571","volume":"279","author":"Molokai","year":"1998","journal-title":"Hawaii: University of"}],"container-title":["American Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ajph.aphapublications.org\/doi\/pdf\/10.2105\/AJPH.89.1.98","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T20:50:43Z","timestamp":1652129443000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajph.aphapublications.org\/doi\/full\/10.2105\/AJPH.89.1.98"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.2105\/AJPH.89.1.98"],"URL":"https:\/\/doi.org\/10.2105\/ajph.89.1.98","relation":{},"ISSN":["0090-0036","1541-0048"],"issn-type":[{"value":"0090-0036","type":"print"},{"value":"1541-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}